A Randomized Clinical Trial of Conscious Sedation vs General Anesthesia on Outcomes in Patients Receiving Thrombectomy for Ischemic Stroke

A Randomized Clinical Trial of Conscious Sedation vs General Anesthesia on Outcomes in Patients... SCIENCE TIMES and Fasudil, unlike simvastatin, decreased demonstrated that patients were 1.71 times n = 73) or conscious sedation (CS; the number of multicavernous lesions, more likely to be functional independent n = 77). There was no difference in and improved survival. Further work is at 3 mo if they received endovascular NIHSS in the either group after 24 h. necessary in order to optimize the efficacy therapy. Subgroup meta-analysis of the Forty-one of 47 secondary outcomes were of ROCK inhibition and better define 6 trials with large vessel occlusion (LVO) not significantly different between the 2 pharmacological safety parameters of confirmation demonstrated even better cohorts including overall 3-mo mortality Fasudil administration. functional outcomes. (24.7%). Stratification of modified Rankin These trials have confirmed the signif- scale (mRS) demonstrated improved icant benefit of endovascular therapy functional independence in the GA group Gregory M. Weiner, MD for ischemic stroke patients with LVO. (37.0%) vs CS (18.2%). Hypothermia, AndrewF.Ducruet,MD These studies also highlighted the fact delayed extubation, and pneumonia Department of Neurosurgery that faster recanalization times lead to were all more frequent in the GA University of Pittsburgh improved outcomes. In a recent meta- cohort. Pittsburgh, Pennsylvania analysis of pooled data from http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Neurosurgery Oxford University Press

A Randomized Clinical Trial of Conscious Sedation vs General Anesthesia on Outcomes in Patients Receiving Thrombectomy for Ischemic Stroke

Loading next page...
 
/lp/ou_press/a-randomized-clinical-trial-of-conscious-sedation-vs-general-hfhkbg6Lqi
Publisher
Oxford University Press
Copyright
Copyright © 2017 by the Congress of Neurological Surgeons
ISSN
0148-396X
eISSN
1524-4040
D.O.I.
10.1093/neuros/nyx113
Publisher site
See Article on Publisher Site

Abstract

SCIENCE TIMES and Fasudil, unlike simvastatin, decreased demonstrated that patients were 1.71 times n = 73) or conscious sedation (CS; the number of multicavernous lesions, more likely to be functional independent n = 77). There was no difference in and improved survival. Further work is at 3 mo if they received endovascular NIHSS in the either group after 24 h. necessary in order to optimize the efficacy therapy. Subgroup meta-analysis of the Forty-one of 47 secondary outcomes were of ROCK inhibition and better define 6 trials with large vessel occlusion (LVO) not significantly different between the 2 pharmacological safety parameters of confirmation demonstrated even better cohorts including overall 3-mo mortality Fasudil administration. functional outcomes. (24.7%). Stratification of modified Rankin These trials have confirmed the signif- scale (mRS) demonstrated improved icant benefit of endovascular therapy functional independence in the GA group Gregory M. Weiner, MD for ischemic stroke patients with LVO. (37.0%) vs CS (18.2%). Hypothermia, AndrewF.Ducruet,MD These studies also highlighted the fact delayed extubation, and pneumonia Department of Neurosurgery that faster recanalization times lead to were all more frequent in the GA University of Pittsburgh improved outcomes. In a recent meta- cohort. Pittsburgh, Pennsylvania analysis of pooled data from

Journal

NeurosurgeryOxford University Press

Published: May 1, 2017

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off